Wednesday, July 8, 2026

Patent intelligence · US

US 10086008

Topical antifungal compositions and methods of use thereof

granted A61KA61K31/137A61K31/4174A61K31/4178
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 12
Applicant portfolio 36
Patent details — US 10086008
Jurisdiction
US
Status
granted
Grant date
Oct 2, 2018
Expiration
Sep 27, 2038
Claims
18
CPC classes
A61K, A61K31/137, A61K31/4174, A61K31/4178
View on Google Patents ↗

Quick answer

US 10086008 (Topical antifungal compositions and methods of use thereof) is held by REVOLUTION PHARMA LLC. Status: granted. Granted Oct 2, 2018. Expires Sep 27, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
18
CPC classes
A61K, A61K31/137, A61K31/4174, A61K31/4178, A61K31/496, A61K31/7048

More from REVOLUTION PHARMA LLC

Related pharmaceutical patents in our USPTO index.

  1. US 12409225

    Ras inhibitors

    Revolution Medicines, Inc. · Expires Sep 4, 2045

    granted
  2. US 12403196

    Ras inhibitors

    Revolution Medicines, Inc. · Expires Aug 28, 2045

    granted
  3. US 12384750

    Ras inhibitors

    Revolution Medicines, Inc. · Expires Aug 7, 2045

    granted
  4. US 12365688

    Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Expires Jul 17, 2045

    granted
  5. US 12280113

    Ras inhibitors

    Revolution Medicines, Inc. · Expires Apr 17, 2045

    granted
  6. US 12258366

    Bicyclic heteroaryl compounds and uses thereof

    Revolution Medicines, Inc. · Expires Mar 20, 2045

    granted
  7. US 12252497

    Ras inhibitors

    Revolution Medicines, Inc. · Expires Mar 13, 2045

    granted
  8. US 12202845

    Ras inhibitors

    Revolution Medicines, Inc. · Expires Jan 16, 2045

    granted

Frequently asked questions

What is US patent 10086008?

US 10086008 (Topical antifungal compositions and methods of use thereof) is held by REVOLUTION PHARMA LLC. Status: granted. Granted Oct 2, 2018. Expires Sep 27, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 10086008?

REVOLUTION PHARMA LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 36 pharmaceutical patents for this assignee.

When does US 10086008 expire?

Our index shows an expiration date of Sep 27, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.